Literature DB >> 25048732

Pulmonary radiographic findings in young children with cystic fibrosis.

Jesiana Ferreira Pedrosa1, Cássio da Cunha Ibiapina, Cristina Gonçalves Alvim, Paulo Augusto Moreira Camargos, Fabiana Paiva Martins, Elizabet Vilar Guimarães, Renata Marcos Bedran.   

Abstract

BACKGROUND: Pulmonary evaluation is one of the greatest challenges in children with cystic fibrosis who are younger than 6 years. Although chest CT can provide the most information for initial and progressive changes in cystic fibrosis, the radiation exposures can lead to significant cumulative exposure in children as they are followed with serial scanning to monitor early and progressive disease. Therefore the systematized study of chest radiographs using the Brasfield score has been used scientifically with the aim of evaluating the evolution of pulmonary abnormalities in children with cystic fibrosis.
OBJECTIVE: This study was performed to assess the radiologic findings in children younger than 6 years with cystic fibrosis. We used the Brasfield score to compare radiographs performed in patients with Pseudomonas aeruginosa vs. oxacillin-sensitive Staphylococcus aureus and to compare radiographs in children with early vs. delayed diagnosis.
MATERIALS AND METHODS: A total of 254 chest radiographs from 67 children who had undergone material cultures of the airways as part of routine care were evaluated in this cross-sectional study. The statistical analysis was performed by the Kruskal-Wallis test, with a significance level of 5%.
RESULTS: Approximately 35.8% of chest radiographs had a Brasfield score lower than 21 points, which is compatible with potentially irreversible pulmonary disease. Brasfield scores decreased (this score decreases with increasing disease severity) in older children, and both bacterial colonization with Pseudomonas and later diagnosis were associated with lower (greater disease) scores.
CONCLUSION: The evaluation of radiographs using the Brasfield score demonstrated the most important pulmonary findings in cystic fibrosis and identified the age group when these alterations began to appear more pronounced.

Entities:  

Mesh:

Year:  2014        PMID: 25048732     DOI: 10.1007/s00247-014-3112-z

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  18 in total

1.  Structural lung changes, lung function, and non-invasive inflammatory markers in cystic fibrosis.

Authors:  Charlotte M H H T Robroeks; Marieke H Roozeboom; Pim A de Jong; Harm A W M Tiddens; Quirijn Jöbsis; Han J Hendriks; Jan-Bart L Yntema; Hein L Brackel; Rene van Gent; Simon Robben; Edward Dompeling
Journal:  Pediatr Allergy Immunol       Date:  2010-05       Impact factor: 6.377

2.  Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1.

Authors:  Brooke M Moore; Theresa A Laguna; Meixia Liu; John J McNamara
Journal:  Pediatr Pulmonol       Date:  2012-09-19

3.  Cystic fibrosis: a system for assessing and predicting progression.

Authors:  R H Cleveland; A S Neish; D Zurakowski; D P Nichols; M E Wohl; A A Colin
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

4.  The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis.

Authors:  Don B Sanders; Zhanhai Li; Michael J Rock; Alan S Brody; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2011-12-13

5.  Cystic fibrosis: predictors of accelerated decline and distribution of disease in 230 patients.

Authors:  R H Cleveland; A S Neish; D Zurakowski; D P Nichols; M E Wohl; A A Colin
Journal:  AJR Am J Roentgenol       Date:  1998-11       Impact factor: 3.959

6.  Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.

Authors:  Philip M Farrell; Zhanhai Li; Michael R Kosorok; Anita Laxova; Christopher G Green; Jannette Collins; Hui-Chuan Lai; Michael J Rock; Mark L Splaingard
Journal:  Am J Respir Crit Care Med       Date:  2003-08-13       Impact factor: 21.405

7.  Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis.

Authors:  Philip M Farrell; Zhanhai Li; Michael R Kosorok; Anita Laxova; Christopher G Green; Jannette Collins; Hui-Chuan Lai; Linda M Makholm; Michael J Rock; Mark L Splaingard
Journal:  Pediatr Pulmonol       Date:  2003-09

Review 8.  Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary.

Authors:  Jeffery T Zobell; David C Young; C Dustin Waters; Krow Ampofo; Chris Stockmann; Catherine M T Sherwin; Michael G Spigarelli
Journal:  Pediatr Pulmonol       Date:  2013-01-28

9.  Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Nicole Mayer-Hamblett; Margaret Rosenfeld; Miriam M Treggiari; Michael W Konstan; George Retsch-Bogart; Wayne Morgan; Jeff Wagener; Ronald L Gibson; Umer Khan; Julia Emerson; Valeria Thompson; Eric P Elkin; Bonnie W Ramsey
Journal:  Pediatr Pulmonol       Date:  2013-07-02

10.  Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis.

Authors:  Margaret Rosenfeld; Philip M Farrell; Margaret Kloster; Jonathan O Swanson; Thuy Vu; Lyndia Brumback; James D Acton; Robert G Castile; Andrew A Colin; Carol K Conrad; Meeghan A Hart; Gwendolyn S Kerby; Peter W Hiatt; Peter J Mogayzel; Robin C Johnson; Stephanie D Davis
Journal:  Eur Respir J       Date:  2013-05-30       Impact factor: 16.671

View more
  1 in total

1.  Chest CT Features of Cystic Fibrosis in Korea: Comparison with Non-Cystic Fibrosis Diseases.

Authors:  So Yeon Yang; Kyung Soo Lee; Min Jae Cha; Tae Jung Kim; Tae Sung Kim; Hyun Jung Yoon
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.